Skip to main content
. Author manuscript; available in PMC: 2013 Nov 15.
Published in final edited form as: Cancer Res. 2012 Sep 19;72(22):6002–6012. doi: 10.1158/0008-5472.CAN-12-0748

Table 1.

Mammary carcinoma multiplicity phenotypes (mean mammary carcinomas per rat ± SD) by genotype for WF.COP Chr 2 congenic lines used to map Mcs1b to 1.8 Mb

WF.COP Chr2 region Line COP/COP (COP/WF) n WF/WF n P value*
D2Uwm17/g2UL2-30 T 3.5±2.2 21 8.3±3.3 19 0.0010
D2Uwm17/D2Ulb4 F3 9.6±4.1 32 8.8±3.5 32 0.8433
D2Mgh2/g2UL1-5 N3 3.4±2.0 25 7.8±3.1 25 0.0001
N3 (5.5±3.6) 15 0.0413
D2Ulb4/ENSRNOSNP2740854 W2 6.0±1.8 18 5.9±3.2 9 0.8498
D2Rat116/ENSRNOSNP2740854 U2 5.7±3.9 6 6.3±3.3 12 0.8866
g2UL2-27/D2Rat201 I4 9.3±3.0 19 7.9±3.7 13 0.2470

Abbreviations: WF, Wistar Furth; COP, Copenhagen; Chr, chromosome

*

P values from Mann Whitney tests

Line T phenotype published previously by Haag et al. Cancer Research, 63:5808–5812, 2003